related bindingとは 意味・読み方・使い方

TUMOR-RELATED PEPTIDE INDISCRIMINATELY BINDING TO HUMAN LEUCOCYTE ANTIGEN (HLA) CLASS II MOLECULE例文帳に追加

無差別的にヒト白血球抗体（ＨＬＡ）クラスＩＩ分子に結合する腫瘍関連ペプチド - 特許庁

To enhance an operability related to the designation of a binding direction while coping with various combination of an original binding direction and an outputted paper binding direction, in the case of both-side copying with a copier.例文帳に追加

複写装置で両面コピーする場合に、原稿の綴じ方向と出力用紙の綴じ方向との各種組み合わせに対応しつつ、綴じ方向の指定に係わる操作性を高める。 - 特許庁

(3) The proposal of the plaintiff pursuant to paragraph 2(d) in the part related to the manner of destruction of the objects shall not be binding for the court.例文帳に追加

(3) (2)(d)にいう物品の廃棄方法に関する請求は，裁判所を拘束しない。 - 特許庁

MEDICINAL COMPOSITION CONTAINING HLA-A24 MOLECULE-BINDING PEPTIDE ORIGINATING IN PARATHYROID HORMONE-RELATED PROTEIN例文帳に追加

ＨＬＡ−Ａ２４分子結合性副甲状腺ホルモン関連蛋白由来ペプチドを含有する医薬組成物 - 特許庁

This invention relates to a ligand comprising following (a) and (b): (a) a first binding region that binds to a component of diseased cells or disease-related vasculatures, or a component of disease-related stroma; the first binding region operatively linked to (b) a coagulation factor or a second binding region that binds to a coagulation factor.例文帳に追加

以下の（ａ）および（ｂ）：（ａ）疾患細胞、疾患関連血管系の成分、または疾患関連支質の成分に結合する第１結合領域；該第１結合領域が作動可能に連結した、（ｂ）凝固因子、または凝固因子に結合する第２結合領域、を含むリガンド。 - 特許庁

To provide antibodies that bind TNF-Related Apoptosis-Inducing Ligand (TRAIL) or antigen-binding fragments thereof.例文帳に追加

ＴＮＦ関連アポトーシス誘導リガンド（ＴＲＡＩＬ）に結合する抗体またはその抗原結合断片を提供する。 - 特許庁

(9) Details related to the submission by means of electronic media shall be stipulated by a generally binding regulation issued by the Office. Filing, which pursuant to the generally binding regulation according to Section 80 has to be supplemented by the submission of a written original within the set time limit, shall not be taken into consideration by the Office in the proceedings in case of failure to meet this obligation.例文帳に追加

(9) 本法に基づく行為に関し，及び特別規則に基づく行為に関しては，特別規則にいう手数料が納付されなければならない。 - 特許庁

The pharmaceutical composition and kit comprise the compound which attenuates the binding of the agouti-related protein to the melanocortin receptor, but does not attenuate the binding of the α-melanocyte stimulating hormone to the melanocortin receptor.例文帳に追加

医薬組成物及びキットは、アグーチ関連タンパク質のメラノコルチンレセプターへの結合を弱めるがα−メラノサイト刺激ホルモンのメラノコルチンレセプターへの結合は弱めない化合物を含む。 - 特許庁